Headlands Technologies’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-90
Closed -$5.44K 1435
2023
Q4
$5.44K Buy
+90
New +$5.44K ﹤0.01% 824